Insufficient weight loss after banded vs. non-banded primary gastric bypass surgery: insights from an observational 5 year follow-up study.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
08 2022
Historique:
received: 30 06 2021
accepted: 06 12 2021
pubmed: 5 1 2022
medline: 19 7 2022
entrez: 4 1 2022
Statut: ppublish

Résumé

While Roux-en-Y gastric bypass (RYGB) is effective in achieving weight loss and improving obesity-related co-morbidities, insufficient weight loss in the long-term can occur. The goal was to assess whether banded vs. non-banded RYGB reduces the risk of insufficient weight loss at 5-year follow-up. This is a retrospective single-center cohort study from Switzerland. We assessed the 5-year metabolic trajectories in terms of body weight, body mass index, glucose control, lipid profile and blood pressure of two surgical cohorts undergoing identical RYGB procedures with or without banding using a uniform 6.5 cm silastic Fobi band. Insufficient weight loss was defined as < 50% excess weight loss (EWL) at 5 years. A total of 55 patients receiving banded (Fobi) and 55 patients receiving non-banded (non-Fobi) RYGB were included in the analysis. 5-year follow-up was 91% for both groups. Percentage of EWL at 5 years was 78.11 ± 26.1% and 73.5 ± 27%.3 for the Fobi vs. non-Fobi group (p = 0.368), respectively. Insufficient weight loss (defined as < 50%EWL) at 5 years or last follow-up was significantly higher in the non-Fobi group compared to the Fobi group (19/55 vs. 9/55, respectively, OR = 2.639 (95% CI 1.066, 6.531), p = 0.036). Surrogate markers for cardiometabolic outcomes consistently improved over time, without differences between the groups. During the follow-up period, Fobi-removal was necessary in nine patients (16.3%). Banded-RYGB lowered the odds of insufficient weight loss at 5 years follow-up by approximately 62%. Further research is needed to explore the effect of restriction on eating behaviour and neuroendocrine responses after RYGB.

Sections du résumé

BACKGROUND
While Roux-en-Y gastric bypass (RYGB) is effective in achieving weight loss and improving obesity-related co-morbidities, insufficient weight loss in the long-term can occur. The goal was to assess whether banded vs. non-banded RYGB reduces the risk of insufficient weight loss at 5-year follow-up.
METHODS
This is a retrospective single-center cohort study from Switzerland. We assessed the 5-year metabolic trajectories in terms of body weight, body mass index, glucose control, lipid profile and blood pressure of two surgical cohorts undergoing identical RYGB procedures with or without banding using a uniform 6.5 cm silastic Fobi band. Insufficient weight loss was defined as < 50% excess weight loss (EWL) at 5 years.
RESULTS
A total of 55 patients receiving banded (Fobi) and 55 patients receiving non-banded (non-Fobi) RYGB were included in the analysis. 5-year follow-up was 91% for both groups. Percentage of EWL at 5 years was 78.11 ± 26.1% and 73.5 ± 27%.3 for the Fobi vs. non-Fobi group (p = 0.368), respectively. Insufficient weight loss (defined as < 50%EWL) at 5 years or last follow-up was significantly higher in the non-Fobi group compared to the Fobi group (19/55 vs. 9/55, respectively, OR = 2.639 (95% CI 1.066, 6.531), p = 0.036). Surrogate markers for cardiometabolic outcomes consistently improved over time, without differences between the groups. During the follow-up period, Fobi-removal was necessary in nine patients (16.3%).
CONCLUSION
Banded-RYGB lowered the odds of insufficient weight loss at 5 years follow-up by approximately 62%. Further research is needed to explore the effect of restriction on eating behaviour and neuroendocrine responses after RYGB.

Identifiants

pubmed: 34981228
doi: 10.1007/s00464-021-08952-7
pii: 10.1007/s00464-021-08952-7
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

5964-5969

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Schauer PR, Bhatt DL, Kirwan JP et al (2017) Bariatric surgery versus intensive medical therapy for diabetes - 5-Year Outcomes. N Engl J Med 376(7):641–651. https://doi.org/10.1056/NEJMoa1600869
doi: 10.1056/NEJMoa1600869 pubmed: 28199805 pmcid: 5451258
Sjöström L, Peltonen M, Jacobson P et al (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307(1):56–65. https://doi.org/10.1001/jama.2011.1914
doi: 10.1001/jama.2011.1914 pubmed: 22215166
King WC, Hinerman AS, Belle SH, Wahed AS, Courcoulas AP (2018) Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes. JAMA 320(15):1560–1569. https://doi.org/10.1001/jama.2018.14433
doi: 10.1001/jama.2018.14433 pubmed: 30326125 pmcid: 6233795
Monaco-Ferreira DV, Leandro-Merhi VA (2017) Weight regain 10 Years after Roux-en-Y gastric bypass. Obes Surg 27(5):1137–1144. https://doi.org/10.1007/s11695-016-2426-3
doi: 10.1007/s11695-016-2426-3 pubmed: 27798793
Sumithran P, Proietto J (2013) The defence of body weight: a physiological basis for weight regain after weight loss. Clin Sci 124(4):231–241. https://doi.org/10.1042/CS20120223
doi: 10.1042/CS20120223
da Silva FB, Gomes DL, de Carvalho KM (2016) Poor diet quality and postoperative time are independent risk factors for weight regain after Roux-en-Y gastric bypass. Nutrition 32(11–12):1250–1253. https://doi.org/10.1016/j.nut.2016.01.018
doi: 10.1016/j.nut.2016.01.018 pubmed: 27544005
Cardeal MA, Faria SL, Faria OP, Facundes M, Ito MK (2016) Diet-induced thermogenesis in postoperatve Roux-en-Y gastric bypass patients with weight regain. Surg Obes Relat Dis 12(5):1098–1107. https://doi.org/10.1016/j.soard.2016.01.019
doi: 10.1016/j.soard.2016.01.019 pubmed: 27178617
Jirapinyo P, Dayyeh BK, Thompson CC (2016) Gastrojejunal anastomotic reduction for weight regain in roux-en-y gastric bypass patients: physiological, behavioral, and anatomical effects of endoscopic suturing and sclerotherapy. Surg Obes Relat Dis 12(10):1810–1816. https://doi.org/10.1016/j.soard.2016.09.036
doi: 10.1016/j.soard.2016.09.036 pubmed: 27998543 pmcid: 5178872
Fobi MA, Lee H (1994) SILASTIC ring vertical banded gastric bypass for the treatment of obesity: two years of follow-up in 84 patients [corrected]. J Natl Med Assoc 86(2):125–128
pubmed: 8169987 pmcid: 2568167
Fried M, Yumuk V, Oppert JM et al (2014) Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg 24(1):42–55. https://doi.org/10.1007/s11695-013-1079-8
doi: 10.1007/s11695-013-1079-8 pubmed: 24081459
Brethauer SA, Kim J, el Chaar M et al (2015) Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis 11(3):489–506. https://doi.org/10.1016/j.soard.2015.02.003
doi: 10.1016/j.soard.2015.02.003 pubmed: 26093765
Zarate X, Arceo-Olaiz R, Montalvo Hernandez J, García-García E, Pablo Pantoja J, Herrera MF (2013) Long-term results of a randomized trial comparing banded versus standard laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 9(3):395–397. https://doi.org/10.1016/j.soard.2012.09.009
doi: 10.1016/j.soard.2012.09.009 pubmed: 23260801
Lemmens L (2017) Banded gastric bypass: better long-term results? a cohort study with minimum 5-year follow-up. Obes Surg 27(4):864–872. https://doi.org/10.1007/s11695-016-2397-4
doi: 10.1007/s11695-016-2397-4 pubmed: 27714527
Coulman KD, MacKichan F, Blazeby JM, Owen-Smith A (2017) Patient experiences of outcomes of bariatric surgery: a systematic review and qualitative synthesis. Obes Rev 18(5):547–559. https://doi.org/10.1111/obr.12518
doi: 10.1111/obr.12518 pubmed: 28273694 pmcid: 5709707
Deden LN, Cooiman MI, Aarts EO et al (2017) Gastric pouch emptying of solid food in patients with successful and unsuccessful weight loss after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis 13(11):1840–1846. https://doi.org/10.1016/j.soard.2017.07.031
doi: 10.1016/j.soard.2017.07.031 pubmed: 28935201
Miholic J, Hoffmann M, Holst JJ et al (2007) Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication. Surg Endosc 21(2):309–314. https://doi.org/10.1007/s00464-005-0804-3
doi: 10.1007/s00464-005-0804-3 pubmed: 17200910
Price HI, Gregory DM, Twells LK (2013) Weight loss expectations of laparoscopic sleeve gastrectomy candidates compared to clinically expected weight loss outcomes 1-year post-surgery. Obes Surg 23(12):1987–1993. https://doi.org/10.1007/s11695-013-1007-y
doi: 10.1007/s11695-013-1007-y pubmed: 23794118
Z’graggen K, Guweidhi A, Steffen R et al (2008) Severe recurrent hypoglycemia after gastric bypass surgery. Obes Surg 18(8):981–988. https://doi.org/10.1007/s11695-008-9480-4
doi: 10.1007/s11695-008-9480-4 pubmed: 18438618

Auteurs

Catherine Tsai (C)

Department of Visceral Surgery, Hirslanden Clinic Beau-Site, Bern, Switzerland.
University of California, San Diego, San Diego, CA, USA.

Maria Dimou (M)

Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.

Markus Naef (M)

Department of Visceral Surgery, Hirslanden Clinic Beau-Site, Bern, Switzerland.

Rudolf Steffen (R)

Department of Visceral Surgery, Hirslanden Clinic Beau-Site, Bern, Switzerland.

Jörg Zehetner (J)

Department of Visceral Surgery, Hirslanden Clinic Beau-Site, Bern, Switzerland.

Christos T Nakas (CT)

Laboratory of Biometry, School of Agriculture, University of Thessaly, Nea Ionia Magnesia, Greece.
University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Lia Bally (L)

Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland. lia.bally@insel.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH